Big pharma is thrilled today after the FDA has rescinded permission for the emergency use of hydroxychloroquine for the treatment of Covid-19.
This after two “prestigious” medical journals have recently been forced to withdraw publication of articles critical of the use of hydroxychloroquine.
The trials cited by the FDA did not include the critical component zinc according to critics, and was thus doomed to fail.
That leaves enormously expensive new drugs in trial and the elusive jjab as the “only way” to end the coronahysteria. Meanwhile states are pushing the idea of a “second wave” and are eyeing another shutdown.
Also read: Association Of American Physicians And Surgeons Sues FDA For ‘Irrational’ Interference Of Access To Life-Saving Hydroxychloroquine